Journal Logo

Poster Session II: Myeloma and other monoclonal gammopathies – Clinica

PS1419 COMPARATIVE EFFECTIVENESS OF TRIPLETS CONTAINING BORTEZOMIB (B), CARFILZOMIB (C), DARATUMUMAB (D), OR IXAZOMIB (I) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) IN ROUTINE CARE IN THE US

Davies, F.1; Rifkin, R.2; Costello, C.3; Usmani, S.4; Abonour, R.5; Palumbo, A.6; Romanus, D.6; Hajek, R.7; Terpos, E.8; Stull, D.M.6; Huang, H.6; Leleu, X.9; Berdeja, J.10; Lee, H.11; Weisel, K.12; Thompson, M.13; Boccadoro, M.14; Zonder, J.15; Cook, G.16; Puig, N.17; Vela-Ojeda, J.18; Skacel, T.6; Farrelly, E.19; Raju, A.19; Blazer, M.19; Chari, A.20

Author Information
doi: 10.1097/01.HS9.0000563952.08050.24
  • Free

Abstract

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.